Cordance Corp. v. Amazon.Com Inc. And
Decision Date | 23 July 2010 |
Docket Number | Civil Action No. 06-491-MPT |
Citation | 727 F.Supp.2d 310 |
Parties | CORDANCE CORPORATION, Plaintiff, v. AMAZON.COM, INC. and, Amazon Web Services, LLC, Defendants. |
Court | U.S. District Court — District of Delaware |
Steven J. Balick, Esquire, John G. Day, Esquire, and Tiffany Geyer Lydon, Esquire, Ashby & Geddes, Wilmington, DE, of Counsel Michael A. Albert, Esquire, Robert M. Abrahamsen, Esquire, and Jeffrey C. O'Neill, Esquire, Wolf, Greenfield & Sacks, P.C., Boston, MA, for Plaintiff Cordance Corporation.
Richard L. Horwitz, Esquire, David E. Moore, Esquire, Potter Anderson & Corroon LLP, Wilmington, DE, of Counsel Lynn H. Pasahow, Esquire, J. David Hadden, Esquire, Darren E. Donnelly, Esquire, Saina S. Shamilov, Esquire, and Ryan J. Marton, Esquire, Fenwick & West LLP, Mountain View, CA, for Defendant Amazon.com, Inc.
This is a patent infringement case. Cordance Corporation ("Cordance") and Amazon.com, Inc. and Amazon Web Services, LLC (collectively, "Amazon") develop software and own patents pertaining to on-line internet-based transaction infrastructures.1 On August 8, 2006, Cordance filed suit alleging that Amazon's trademarked "1-Click®" purchasing interface, featured throughout its website, infringed U.S. Patent No. 6,757,710 ("the '710 patent"). On September 7, 2006, Cordance filed its first amended complaint. On October 23, 2006 Amazon filed its answer asserting numerous counterclaims and defenses, including a counterclaim of patent infringement of its U.S. Patent No. 6,269,369 ("the '369 patent").2 On November 11, 2007, Cordance filed its second amended complaint, which alleged that Amazon's information storage processes infringed U.S. Patent No. 6,044,205 ("the '205 patent") and that Amazon's systems for collecting, retrieving, and presenting product reviews and buyer and seller feedback infringe U.S. Patent Nos. 5,862,325 ("the '325 patent") and 6,088,717 ("the 717 patent").3 Subsequently, Cordance and Amazon stipulated to a dismissal of claims and counterclaimsrelating to infringement of Cordance's ' 205 patent and Amazon's ' 369 patent.4 As a result, by the time this case was tried, the patents in suit were Cordance's '325, 717, and 710 patents.
A jury trial commenced on August 3, 2009. On August 18, 2009, the jury reached a verdict, finding (1) Amazon does not infringe any of the asserted claims of the 5 6 7 8 9 10 710 patent under that doctrine and the doctrine of patent misuse.
Applicants for patents and their legal representatives owe a duty of candor, good faith, and honesty in their dealings with the United States Patent and Trademark Office ("PTO").11 A breach of this duty constitutes inequitable conduct.12 And if inequitable conduct is established, then the entire patent is rendered unenforceable.13
To successfully prove inequitable conduct, an accused infringer must present " 'evidence that the applicant (1) made an affirmative misrepresentation of material fact, failed to disclose material information, or submitted false material information, and (2) intended to deceive the [PTO].' " 14A threshold level of each element-materiality and intent to deceive-must be proven by clear and convincing evidence. 15 Further, even if the requisite clear and convincing showing of both elements has been made, a court may still choose not to invalidate the challenged patent.16
The following is the standard for materiality: "information is material when a reasonable examiner would consider it important in deciding whether to allow the application to issue as a patent." 17 With regard to the deceptive intent prong, " 'materiality does not presume intent, which is a separate and essential component of inequitable conduct.' " 18 " " 19 Such intent can be inferred from indirect and circumstantial evidence,20 "[b]ut such evidence must still be clear and convincing, and inferences drawn from lesser evidence cannot satisfy the deceptive intent requirement." 21 Moreover, "the inference must not only be based on sufficient evidence and be reasonable in light of that evidence, but it must also be the single most reasonable inference able to be drawn from the evidence to meet the clear and convincing standard." 22
A district court cannot find inequitable conduct unless threshold levels of both intent to deceive and materiality are established by clear and convincing evidence.23 "Only after adequate showings are made as to both materiality and deceptiveintent may the district court look to the equities by weighing the facts underlying those showings." 24 At this stage in a court's inequitable conduct analysis, the inverse relationship between materiality and intent to deceive comes into play, and a court facing a high level of materiality may find that inequitable conduct has been established despite a lower level showing of intent to deceive.25 The Federal Circuit has explained:
At this second stage, ... the question is no longer whether materiality and/or intent to deceive were proven with evidence that is sufficiently clear and convincing. While the facts of materiality and intent to deceive must be proven by clear and convincing evidence, the district court must balance the substance of those now-proven facts and all the equities of the case to determine whether the severe penalty of unenforceability should be imposed. It is this balancing that is committed to the district court's discretion. 26
The prosecution history of the 325 patent filed on September 27, 1996, which is a continuation in part 28 of the ' 205 patent filed on February 29, 1996.29
In a final office action mailed February 28, 2003, the 31 710 patent claims were amended, two claims were added, and the ' 710 patent inventor, Drummond Reed ("Reed"), filed a Rule 131 declaration 32 purportedly establishing that the Chelliah patent was not prior art to either method claimed in the ' 710 patent.33 In his Rule 131 declaration (the "131 Declaration") Reed swore that he conceived of the two claimed methods prior to the August 29, 1995 effective date of the Chelliah patent and diligently worked toward reducing those methods to practice.34 Attached as Appendix A to Reed's 131 declaration was a document entitled Access Object Network Disclosure Document (the "Conception Document") and dated November 1, 1993.35
Because Amazon's allegations of inequitable conduct turn on relationships between representations in Reed's 131 Declaration and the Conception Document, the court reproduces, with some explication interspersed, select portions of these documents. In his 131 Declaration, Reed first declares that his Conception Document shows conception of each element of the '710 patent's two methods for completing online purchases, which he terms the "First Method" and the "Second Method." The 131 Declaration begins:
To continue reading
Request your trial-
Otsuka Pharm. Co. v. Torrent Pharm. Ltd.
...; Altana Pharma AG v. Teva Pharm. USA, Inc., No. 04–2355, 2012 WL 2068611 (D.N.J. June 7, 2012) ; Cordance Corp. v. Amazon.com, Inc., 727 F.Supp.2d 310, 333–34 (D.Del. July 23, 2010) ; In re Gabapentin Patent Litig., 648 F.Supp.2d 641, 652 (D.N.J.2009). Here, the Court need not belabor Torr......
-
Otsuka Pharm. Co. v. Apotex Corp.
...; Altana Pharma AG v. Teva Pharm. USA, Inc., No. 04–2355, 2012 WL 2068611 (D.N.J. June 7, 2012) ; Cordance Corp. v. Amazon.com, Inc., 727 F.Supp.2d 310, 333–34 (D.Del.2010) ; In re Gabapentin Patent Litig., 648 F.Supp.2d 641, 652 (D.N.J.2009). As a result, in Torrent, the Court dismissed th......
-
Otsuka Pharm. Co. v. Apotex Corp.
...Altana Pharma AG v. Teva Pharm. USA, Inc., No. 04-2355, 2012 WL 2068611 (D.N.J. June 7, 2012); Cordance Corp. v. Amazon.com, Inc., 727 F. Supp. 2d 310, 333-34 (D. Del. July 23, 2010); In re Gabapentin Patent Litig., 648 F. Supp. 2d 641, 652 (D.N.J. 2009). As a result, in Torrent, the Court ......
-
Otsuka Pharm. Co. v. Apotex Corp., Civil Action No. 14-8074 (JBS/KMW)
...Altana Pharma AG v. Teva Pharm. USA, Inc., No. 04-2355, 2012 WL 2068611 (D.N.J. June 7, 2012); Cordance Corp. v. Amazon.com, Inc., 727 F. Supp. 2d 310, 333-34 (D. Del. July 23, 2010); In re Gabapentin Patent Litig., 648 F. Supp. 2d 641, 652 (D.N.J. 2009). As a result, in Torrent I, the Cour......
-
Specific Practices That Have Been Challenged as Misuse
...that the 104. 502 F.3d 1014 (9th Cir. 2007). 105. Id . at 1023. 106. Id. at 1016. 107. Id. at 1023. 108. Id. 109. Id. at 1024. 110. 727 F. Supp. 2d 310 (D. Del. 2010). 111. Id . at 334. 112. Id. at 335. 113. Id. 80 Intellectual Property Misuse licensor in Cordance did not improperly leverag......